SOLICITATION NOTICE
B -- GENE TARGETING SERVICE
- Notice Date
- 7/28/2010
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- National Institutes of HealthNational Library of Medicine6707 DemocracySuite 700WBethesdaMD20892-7511
- ZIP Code
- 20892-7511
- Solicitation Number
- NIHLM2010073
- Response Due
- 8/12/2010
- Archive Date
- 9/11/2010
- Point of Contact
- OWENS-COBBLAH, SONYA +1 301 594 4666, owenscobblahs@mail.nih.gov
- E-Mail Address
-
OWENS-COBBLAH, SONYA
(owenscobblahs@mail.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- This is a combined synopsis/solicitation for commercial items prepared in accordance with the format under Simplified Acquisition Procedures at Federal Acquisition Regulation (FAR) Subpart 12.6, Streamlined Procedures for Evaluation and Solicitation for Commercial Items; and FAR Subpart 13.5, Test Program for Certain Commercial Items; as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. This solicitation is being issued as Request for Quotations (RFQ) NLM-2010-073.. This solicitation document incorporates provisions and clauses that are in effect in the March 2005 Federal Acquisition Regulation (FAR) Revision, including all FAR Circulars issued as of the date of this synopsis. The North American Industry Classification System (NAICS) code is 334516. It is the intent of the National Institute of Diabetes and Digestive and Kidney Diesease, National Institutes of Health (NIH), to negotiate and acquire services to study the function of UDP-GalNAc: polypeptide alpha-N cetylgalactosaminyltransferases (ppGalNAcT), a family of proteins responsible for adding O-linked glycans to protein backbones. This is a service contract for gene targeted mouse testing and animal physiology. This contract will include lab testing, studies, and data analysis of mice. The services to be performed are electroporation of ES cells with constructs generated in the NIDDK lab, screening for positive ES cell clones, injection of positive ES cells into blastocysts to generate chimeric mice, housing and breeding of chimeric mice, and genotyping to identify gene targeted offspring. The contract vehicle is a Firm Fixed price contract. The period of performance is August 2010 - April 2011. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. The solicitation number is NIH-NLM-010-073 and the solicitation is issued as a request for quotation (RFQ). However, all responses received before the closing date of this announcement will be considered by the Government. All responsible sources may submit a quotation which, if timely received, shall be considered by the agency. The following clauses and provisions cited herein are incorporated by reference into this solicitation and may be obtained from the web site http://rcb.cancer.gov/rcb-internet/SAP/sap.htm: FAR 52.212-1, Instructions to Offerors - Commercial (September 2006), and FAR 52.212-4, Contract Terms and Conditions - Commercial Items (February 2007). The attached Addendum to Terms and Conditions of Purchase Order also applies to this solicitation. FAR 52.212-2, Evaluation - Commercial Items (January 1999)
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIHL/NIHLM2010073/listing.html)
- Record
- SN02221170-W 20100730/100728235852-f3e60341c0049367d397d8340608721c (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |